Skip to main content
Log in

Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

The aim of this study was to investigate the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in a geriatric population in Turkey and compare bone mineral densities and related laboratory parameters of MGUS patients with those who do not have MGUS. Among 1,012 patients enrolled, monoclonal band was detected in serum samples of 22 patients (2.17%), most of which were IgG type. Further tests revealed multiple myeloma and lung carcinoma in two patients. The remaining 20 patients were diagnosed with MGUS (1.97%). The clinical and laboratory parameters of patients with and without MGUS were mostly comparable; however, bone mineral density measurements of patients with MGUS were significantly lower than those without MGUS (p = 0.007). We suggest evaluation of geriatric patients with MGUS for the presence of osteopenia/osteoporosis considering the high frequency observed in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rajkumar SV (2005) MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management. Hematology 340–345 (Am Soc Hematol Educ Program)

  2. Kyle RA, Rajkumar SV (2006) Monoclonal gammopathy of undetermined significance. Br J Haematol 134:573–589

    Article  PubMed  CAS  Google Scholar 

  3. Kyle RA, Therneau TM, Rajkumar SV et al (2004) Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc 79:859–866

    Article  PubMed  Google Scholar 

  4. Pecherstorfer M, Seibel MJ, Woitge HW et al (1997) Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen. Blood 90:3743–3750

    PubMed  CAS  Google Scholar 

  5. Vejlgaard T, Abildgaard N, Jans H et al (1997) Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens. Eur J Haematol 58:104–108

    Article  PubMed  CAS  Google Scholar 

  6. Politou M, Terpos E, Anagnostopoulos A et al (2004) Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 126:686–689

    Article  PubMed  CAS  Google Scholar 

  7. Melton LJ 3rd, Rajkumar SV, Khosla S et al (2004) Fracture risk in monoclonal gammopathy of undetermined significance. J Bone Miner Res 19:25–30

    Article  PubMed  Google Scholar 

  8. Axelsson U, Bachmann R, Hallen J (1966) Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. Acta Med Scand 179:235–247

    Article  PubMed  CAS  Google Scholar 

  9. Saleun JP, Vicariot M, Deroff P et al (1982) Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol 35:63–68

    Article  PubMed  CAS  Google Scholar 

  10. Crawford J, Eye MK, Cohen HJ (1987) Evaluation of monoclonal gammopathies in the “well” elderly. Am J Med 82:39–45

    Article  PubMed  CAS  Google Scholar 

  11. Kyle RA, Rajkumar SV (2003) Monoclonal gammopathies of undetermined significance: a review. Immunol Rev 194:112–139

    Article  PubMed  CAS  Google Scholar 

  12. Ozkalemkas F, Ali R, Tunali A, Ozkocaman V, Ozyardimci C, Ozcelik T (1996) Multiple myeloma in the region of Bursa, Turkey: a retrospective analysis. J Environ Pathol Toxicol Oncol 15:267–270

    PubMed  CAS  Google Scholar 

  13. Bataille R, Chappard D, Basle MF (1996) Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies. Blood 87:4762–4769

    PubMed  CAS  Google Scholar 

  14. Dizdar O, Barista I, Kalyoncu U et al (2006) Biochemical markers of bone turnover in diagnosis of myeloma bone disease. Am J Hematol 82:185–191

    Article  CAS  Google Scholar 

  15. Jakob C, Zavrski I, Heider U et al (2002) Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma. Eur J Haematol 69:37–42

    Article  PubMed  CAS  Google Scholar 

  16. Diamond T, Levy S, Smith A et al (2001) Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance. Intern Med J 31:272–278

    Article  PubMed  CAS  Google Scholar 

  17. Pepe J, Petrucci M, Nofroni I et al (2006) Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 134:485–490

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Omer Dizdar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dizdar, O., Erman, M., Cankurtaran, M. et al. Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance. Ann Hematol 87, 57–60 (2008). https://doi.org/10.1007/s00277-007-0376-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-007-0376-5

Keywords

Navigation